Viewing Study NCT00167414



Ignite Creation Date: 2024-05-05 @ 11:53 AM
Last Modification Date: 2024-10-26 @ 9:15 AM
Study NCT ID: NCT00167414
Status: COMPLETED
Last Update Posted: 2018-01-05
First Post: 2005-09-09

Brief Title: Study for Using Radiosurgery on Limited Metastases of Breast Cancer
Sponsor: University of Rochester
Organization: University of Rochester

Study Overview

Official Title: A Phase II Study for Using Radiosurgery on Limited Metastases of Breast Cancer
Status: COMPLETED
Status Verified Date: 2017-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to evaluate whether radiosurgery along with standard chemotherapy immunotherapy the treatment of cancer by modulating the immune system and immune response or hormonal therapy affects the quality and length of life The standard therapy is surgery radiation therapy or chemotherapy alone or in any combination A second purpose of this study is to determine if the levels of a special type of protein called cytokines found in the blood are related to the quality of life while on this treatment
Detailed Description: Before treatment begins you will have a physical exam and blood tests Physical evaluations and blood tests will be done each week while you are receiving treatment and at follow-up visits You will be seen for follow-up evaluations 4 weeks after treatment is completed and every three months thereafter You will be asked to fill out a Quality of Life questionnaire which should take 5-10 minutes to complete This will be done prior to treatment and at your follow-up visits You will receive high dose radiation therapy directed at the site of metastasis This treatment will be given once a day 5 times a week Monday through Friday for one to four weeks depending on the location and size of the disease to be treated

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None